These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8590963)
1. 5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 alpha, 17 beta-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study. Wudy SA; Wachter UA; Homoki J; Teller WM Eur J Endocrinol; 1996 Jan; 134(1):87-92. PubMed ID: 8590963 [TBL] [Abstract][Full Text] [Related]
2. [Gas chromatography-mass spectrometry determination of plasma 5 alpha-androstane-3 alpha,17 beta-diol and 5 alpha-androstane-3 alpha,17 beta-diol glucuronide in children with premature and normal puberty ]. Wudy SA; Homoki J; Teller WM Klin Padiatr; 1996; 208(6):334-8. PubMed ID: 9064375 [TBL] [Abstract][Full Text] [Related]
3. Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women? Giagulli VA; Giorgino R; Vermeulen A J Steroid Biochem Mol Biol; 1991 Jul; 39(1):55-61. PubMed ID: 1829956 [TBL] [Abstract][Full Text] [Related]
4. Unconjugated 5 alpha-androstan-3 alpha, 17 beta-diol and 5 alpha-androstane-3 beta, 17 beta-diol in human plasma as measured by radioimmunoassay without chromatography. Tamm J; Volkwein U J Clin Chem Clin Biochem; 1981 May; 19(5):291-4. PubMed ID: 7264570 [TBL] [Abstract][Full Text] [Related]
5. Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A. Vexiau P; Fiet J; Boudou P; Villette JM; Feutren G; Hardy N; Julien R; Dreux C; Bach JF; Cathelineau G J Steroid Biochem; 1990 Jan; 35(1):133-7. PubMed ID: 2137888 [TBL] [Abstract][Full Text] [Related]
6. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. Horton R; Hawks D; Lobo R J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855 [TBL] [Abstract][Full Text] [Related]
7. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633 [TBL] [Abstract][Full Text] [Related]
10. Serum androstanediol glucuronide in women with facial hirsutism. Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146 [TBL] [Abstract][Full Text] [Related]
11. The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay. Laband P; Tresguerres JA; Lisboa BP; Volkwein U; Tamm J Acta Endocrinol (Copenh); 1978 Aug; 88(4):778-86. PubMed ID: 581118 [TBL] [Abstract][Full Text] [Related]
12. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. Greep N; Hoopes M; Horton R J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268 [TBL] [Abstract][Full Text] [Related]
13. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women. Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide concentration in clinically euthyroid women with suppressed plasma thyrotropin levels: further evidence for generalized tissue overexposure to thyroid hormones in these subjects. Giagulli VA; Vermeulen A J Clin Endocrinol Metab; 1992 Jun; 74(6):1465-7. PubMed ID: 1592894 [TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism. Kirschner MA; Samojlik E; Szmal E J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women. Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314 [TBL] [Abstract][Full Text] [Related]
18. A highly specific heterologous enzyme immunoassay for 5 alpha-androstane-3 alpha, 17 beta-diol 17-glucuronide (androstanediol-17G) and developmental patterns of urinary androstanediol-17G excretions. Onishi T; Takei H; Kambegawa A; Saisho S; Kashimada K; Koyama S; Mizutani S; Rao PN Steroids; 2002 Mar; 67(3-4):175-83. PubMed ID: 11856541 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B; Slopien R; Warenik-Szymankiewicz A Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [TBL] [Abstract][Full Text] [Related]
20. Plasma androstanediol glucuronide levels during pregnancy. van Droogenbroeck J; Vermeulen A Clin Endocrinol (Oxf); 1989 Oct; 31(4):425-9. PubMed ID: 2534065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]